abnormal cytokine secretion_Ido1<tm1Alm>/Ido1<tm1Alm>

http://metadb.riken.jp/0003009I129X1SvJC57BL6CBAIdo1tm1AlmIdo1tm1AlmIdo1tm1Alm

abnormal cytokine secretion_Ido1<tm1Alm>/Ido1<tm1Alm>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• indoleamine 2,3-dioxygenase 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:96416

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Ido1<tm1Alm>/Ido1<tm1Alm>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ido1<tm1Alm>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129X1/SvJ * C57BL/6 * CBA

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal cytokine secretion
  http://purl.obolibrary.org/obo/MP_0003009

文献

http://purl.org/net/cito/citesAsAuthority

• Anna K. Manlapat, et.al., Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells., European journal of immunology, 2007, 37
  http://rdf.ncbi.nlm.nih.gov/pubmed/17343295